Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
23andMe Buyback: Wojcicki 5M Deal

23andMe Buyback: Wojcicki $305M Deal

June 14, 2025 Catherine Williams - Chief Editor News

Anne Wojcicki’s TTAM Research Institute‌ has won‍ the⁤ bid to acquire⁣ 23andMe for $305 million, ‍securing the ​future‍ of the⁤ genetic testing company. this decisive move sees the co-founder and former CEO ⁢regaining control after the⁤ company’s bankruptcy filing.The deal encompasses 23andMe’s core services, including ​the Personal Genome Service. Wojcicki’s nonprofit ⁣bid ‌outmaneuvered‌ Regeneron Pharmaceuticals, signaling⁢ a‍ key shift for the brand. The acquisition is subject to ‍court ⁣approval. news Directory 3 provides comprehensive coverage of ‍this ⁢breaking story. Learn how 23andMe, once valued at $6‌ billion, navigated financial struggles. The data confirms the buyback aims to revive the mission of 23andMe. Discover what’s next …

Key Points

  • Anne‌ Wojcicki’s TTAM ⁤Research ‌Institute acquires 23andMe for $305 million.
  • The deal includes⁤ 23andMe’s Personal⁢ Genome Service and Lemonaid ⁢health.
  • Wojcicki stepped down as CEO when 23andMe filed for bankruptcy in March.
  • The acquisition ‌is subject to ⁢court approval.

Wojcicki’s TTAM Wins Bid for 23andMe,‌ Genetic​ Testing Role Secured

‌ ​ ⁢ Updated June 14, 2025
​ ‍

Anne Wojcicki, co-founder and former⁢ CEO, is set to regain‌ control of 23andMe. Her ‍new⁣ nonprofit, ⁤TTAM Research Institute, successfully ​bid $305 million for substantially all of 23andMe’s ⁢assets, including its Personal Genome Service, Research Services, and telehealth subsidiary Lemonaid Health. This outcome follows 23andMe’s Chapter 11 bankruptcy filing in ⁤March.

TTAM’s winning bid surpassed an earlier offer of $256 million from Regeneron Pharmaceuticals. Wojcicki ​then pushed to ‌reopen the auction. ⁣TTAM is an acronym derived ⁤from‍ the first letters of ⁢23andMe.

The genetic testing company,‌ once​ valued​ at‍ $6 billion ​after going‌ public‌ in 2021, struggled ‍with revenue generation and research progress. A 2023 data breach compromised the ⁣information of nearly 7 million customers, further compounding its challenges.

23andMe gained popularity offering at-home ⁣DNA kits, providing insights​ into ancestry and genetic predispositions.

⁢ “I am thrilled that TTAM Research Institute will be able to continue the mission‌ of 23andMe to help people access, understand and benefit ⁤from‌ the human⁢ genome,” Wojcicki said.
‌ ⁣

What’s next

The acquisition by TTAM Research Institute ⁤awaits approval from the U.S. Bankruptcy ⁣Court for ⁤the Eastern District of Missouri.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Copyright Notice
  • Disclaimer
  • Terms and Conditions

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service